Clinical Trials Logo

Filter by:
NCT ID: NCT05725772 Completed - Parkinson Disease Clinical Trials

Comparison of Health Care Delivery Methods in Parkinson's Disease

Start date: December 13, 2022
Phase:
Study type: Observational

The goal of this observational study is to compare the ability to perform telemedicine visits at home, at a regional clinic close to home, and in-person in People with Parkinson's disease. The main question it aims to answer is whether telemedicine assessments provide high quality care to people with Parkinson's disease. Participants will perform a regular clinic visit followed by research evaluations of their disease. Researchers will compare the results of these assessments at the different visit types to see if there are differences in the results.

NCT ID: NCT05725746 Completed - Postpartum Clinical Trials

Feasibility of Remote Data Collection With a Point of Care Device to Measure HbA1c

Start date: February 24, 2023
Phase:
Study type: Observational

Conduct a pilot study to test feasibility of doing remote data collection with a point of care device that measures HbA1c.

NCT ID: NCT05725525 Completed - Disruptive Behavior Clinical Trials

A Study of Internet Delivered Parent Child Interaction Therapy

AI I-PCIT
Start date: March 2, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to learn more about how feasible remote parent child interaction therapy (PCIT) is for children with disruptive behaviors and how to augment treatment with wearable devices.

NCT ID: NCT05725408 Completed - Binge Eating Clinical Trials

Comparison of a Telehealth Versus In-person Intervention for Binge Eating

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

Adults and adolescents will be asked to participate in a 10-week intervention to better understand their emotions and improve their relationship with food.

NCT ID: NCT05725109 Completed - Hepatitis C Clinical Trials

Hepatitis C Diagnosis to Treatment Management

Start date: January 16, 2023
Phase:
Study type: Observational

The objective of this study is to evaluate whether sending alerts to healthcare providers and clinic staff to identify patients with untreated hepatitis C infection can increase the uptake of hepatitis C treatment. A period of time without alerts will be compared to a period of time with alerts.

NCT ID: NCT05724901 Completed - Multiple Sclerosis Clinical Trials

At-Home Gait Assessment

Start date: January 11, 2023
Phase:
Study type: Observational

The goal of this study is to validate an MS Gait Remote Capture and Analysis (MS-GRCA) system based on wearable shoe-based motion sensors for home-based and repeatable gait assessments.

NCT ID: NCT05724615 Completed - Clinical trials for Atherosclerotic Cardiovascular Disease

Default Bulk Ordering and Text Messaging to Enhance Outreach for Lipid Screening (Missing Lipids)

Start date: June 5, 2023
Phase: N/A
Study type: Interventional

We aim to evaluate different approaches to increase Lipid screenings among primary care patients at Penn Medicine. A randomized trial will test the effectiveness of bulk ordering, outreach via mailed letters, and text-based reminders with scheduling assistance for patients needing a lipids panel. We will observe the number of completed panels after 3 and 6 months.

NCT ID: NCT05723822 Completed - Clinical trials for Mild Cognitive Impairment

Effects of Walkasins on Gait Speed of Individuals With Mild Cognitive Impairments

Start date: February 16, 2023
Phase: N/A
Study type: Interventional

The primary aim of this pilot study is to investigate the effect of Walkasins, a wearable lower-limb sensory prosthesis, on the gait speed and balance function of participants with mild cognitive impairment as measured by the Saint Louis University Mental Status (SLUMS) Examination.

NCT ID: NCT05723770 Completed - Clinical trials for Dry Eye Disease (DED)

Effects of NOV03 on the Tear Film

Start date: August 14, 2023
Phase: Phase 4
Study type: Interventional

Determine the effect of a single instillation of NOV03 on the thickness and evaporation rate of the mucus-aqueous layer of the tear film

NCT ID: NCT05723692 Completed - Healthy Volunteers Clinical Trials

A First-In-Human SAD and MAD Study to Evaluate the Safety, Tolerability, PK and PD of SC Administered ALTB-268 in Healthy Volunteers

Start date: January 17, 2023
Phase: Phase 1
Study type: Interventional

This study with ALTB-268 will determine the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple ascending doses of ALTB-268 in healthy volunteers.